Immunological impact of age and comorbidities: findings from the REALISM and SENIOR-HLA-DR cohorts

BACKGROUND: The ageing population faces numerous physiological changes, among which immunosenescence plays a central role. Understanding the mechanisms underlying immunosenescence remains a priority. Within this framework, the contribution of comorbidities to immune dysfunction is still poorly characterized, despite growing evidence suggesting that it may represent a critical determinant in the evaluation of immunosenescence. The main objective of this report was to disentangle the respective impacts of age and comorbidities. To this end, we focused on immunological parameters originally developed in the context of sepsis, a condition that shares many immunological defects with immunosenescence. METHODS: Data were obtained from two cohorts: the REALISM cohort, including healthy elderly individuals, and the SENIOR-HLA-DR cohort, consisting of a real-life hospitalized geriatric population. Immunological parameters assessed were circulating IL-6, percentage of immature neutrophils, monocyte HLA-DR expression (mHLA-DR), neutrophil-to-lymphocyte ratio (NLR), T lymphocyte count, and interferon-γ release assay (IGRA) in response to phytohemagglutinin (PHA). RESULTS: In the absence of comorbidities, age had no detectable effect on immune parameters in the REALISM cohort (n = 174 individuals). The SENIOR-HLA-DR cohort (n = 76 patients) revealed that cardiovascular comorbidities exerted the greatest influence, being associated with significantly reduced mHLA-DR expression and increased NLR. Infections further triggered substantial alterations in inflammation and innate immunity, characterized by elevated percentages of immature neutrophils and decreased mHLA-DR expression. DISCUSSION-CONCLUSIONS: Our findings indicate a limited impact of chronological age and comorbidities on the selected immunological parameters. These results suggest that routine clinical tools may be insufficient to fully capture the complexity of immunosenescence.

Authors

Institutions

Publication Details

Journal
Aging Clinical and Experimental Research
Published
2026-04-17
DOI
https://doi.org/10.1007/s40520-026-03389-1
Primary Topic
Immune responses and vaccinations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunological impact of age and comorbidities: findings from the REALISM and SENIOR-HLA-DR cohorts

Guillaume Monneret, Morgane Gossez, Maxime Bodinier, Sylvain Gaujard et al.
Aging Clinical and Experimental Research
Immune responses and vaccinations
article

Immunological impact of age and comorbidities: findings from the REALISM and SENIOR-HLA-DR cohorts

Guillaume Monneret, Morgane Gossez, Maxime Bodinier, Sylvain Gaujard, Fabienne Venet, Anne‐Perrine Foray, L. Vieilledent, Constance Dumay, Samuel Le Goff, Anne Broyer, Karine Di-Valentin, Elisa Renaud
article en

Abstract

BACKGROUND: The ageing population faces numerous physiological changes, among which immunosenescence plays a central role. Understanding the mechanisms underlying immunosenescence remains a priority. Within this framework, the contribution of comorbidities to immune dysfunction is still poorly characterized, despite growing evidence suggesting that it may represent a critical determinant in the evaluation of immunosenescence. The main objective of this report was to disentangle the respective impacts of age and comorbidities. To this end, we focused on immunological parameters originally developed in the context of sepsis, a condition that shares many immunological defects with immunosenescence. METHODS: Data were obtained from two cohorts: the REALISM cohort, including healthy elderly individuals, and the SENIOR-HLA-DR cohort, consisting of a real-life hospitalized geriatric population. Immunological parameters assessed were circulating IL-6, percentage of immature neutrophils, monocyte HLA-DR expression (mHLA-DR), neutrophil-to-lymphocyte ratio (NLR), T lymphocyte count, and interferon-γ release assay (IGRA) in response to phytohemagglutinin (PHA). RESULTS: In the absence of comorbidities, age had no detectable effect on immune parameters in the REALISM cohort (n = 174 individuals). The SENIOR-HLA-DR cohort (n = 76 patients) revealed that cardiovascular comorbidities exerted the greatest influence, being associated with significantly reduced mHLA-DR expression and increased NLR. Infections further triggered substantial alterations in inflammation and innate immunity, characterized by elevated percentages of immature neutrophils and decreased mHLA-DR expression. DISCUSSION-CONCLUSIONS: Our findings indicate a limited impact of chronological age and comorbidities on the selected immunological parameters. These results suggest that routine clinical tools may be insufficient to fully capture the complexity of immunosenescence.

Aging Clinical and Experimental Research
Université Claude Bernard Lyon 1 (FR), École Normale Supérieure de Lyon (FR), Institut Mérieux (France) (FR), Centre National de la Recherche Scientifique (FR), Inserm (FR), Hôpital de la Croix-Rousse (FR), Hospices Civils de Lyon (FR), Centre International de Recherche en Infectiologie (FR)
Gender equality
Openalex Percentile: Top 14%
Immune responses and vaccinations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.